James McCallum Noble

James McCallum Noble

Auto-generated profile, based on publicly available information

James McCallum Noble

Department of Neurology & GH Sergievsky Center Columbia University New York New York USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
DNDominantly Inherited Alzheimer Network
Dominantly Inherited Alzheimer Network
OPOliver Preische
Oliver Preische
SSStephanie A. Schultz
Stephanie A. Schultz
AAAnja Apel
Anja Apel
JKJens Kuhle
Jens Kuhle
MJMathias Jucker
Mathias Jucker

2 October 2018 in Neurology
Verified
Journal Article
Closed access
PDF file
EMEric McDade
Eric McDade
GWGuoqiao Wang
Guoqiao Wang
BGBrian A. Gordon
Brian A. Gordon
JHJason Hassenstab
Jason Hassenstab
TBTammie L.S. Benzinger
Tammie L.S. Benzinger
RKRobert Koeppe
Robert Koeppe
Objective To assess the onset, sequence, and rate of progression of comprehensive biomarker and clinical measures across the spectrum of Alzheimer disease (AD) using the Dominantly Inherited Alzheimer Network (DIAN) study and compare these to cross-sectional estimates. Methods We conducted longitudinal clinical, cognitive, CSF, and neuroimaging assessments (mean of 2.7 [±1.1] visits) in 217 DIAN participants. Linear mixed effects models were used to assess changes in each measure relative to individuals9 estimated years to symptom onset and to compare mutation carriers and noncarriers. Results Longitudinal β-amyloid measures changed first (starting 25 years before estimated symptom onset), followed by declines in measures of cortical metabolism (approximately 7–10 years later), then cognition and hippocampal atrophy (approximately 20 years later). There were significant differences in the estimates of CSF p-tau181 and tau, with elevations from cross-sectional estimates preceding longitudinal estimates by over 10 years; further, longitudinal estimates identified a significant decline in CSF p-tau181 near symptom onset as opposed to continued elevations. Conclusion These longitudinal estimates clarify the sequence and temporal dynamics of presymptomatic pathologic changes in autosomal dominant AD, information critical to a better understanding of the disease. The pattern of biomarker changes identified here also suggests that once β-amyloidosis begins, additional pathologies may begin to develop less than 10 years later, but more than 15 years before symptom onset, an important consideration for interventions meant to alter the disease course.

5 May 2009 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
JNJ M Noble
J M Noble
LBLuisa N. Borrell
Luisa N. Borrell
PPP N Papapanou
P N Papapanou
MEM S V Elkind
M S V Elkind
NSN Scarmeas
N Scarmeas
CWC B Wright
C B Wright
Background: Periodontitis is ubiquitous and associated with serological evidence of exposure to periodontal organisms, systemic inflammation and vascular disease. Dementia is a major public health problem likely related to a complex interaction between genetics and diseases associated with systemic inflammation, including diabetes, smoking and stroke. Methods: To assess relationships between systemic exposure to periodontal pathogens and cognitive test outcomes, data were analysed from the Third National Health and Nutrition Examination Survey (NHANES-III), a nationally representative cross sectional observational study among older adults. We included 2355 participants ⩾60 years who completed measures of cognition and Poryphyromonas gingivalis IgG. Using SUDAAN, logistic regression models examined the association of P gingivalis IgG with cognitive test performance. Results: Poor immediate verbal memory (<5/9 points) was prevalent in 5.7% of patients, and 6.5% overall had impaired delayed recall (<4/9); 22.1% had difficulty with serial subtractions (119 ELISA Units (EU)) were more likely to have poor delayed verbal recall (OR 2.89, 95% CI 1.14 to 7.29) and impaired subtraction (OR 1.95, 95% CI 1.22 to 3.11) than those with the lowest (⩽57 EU), with dose–response relationships for both (p trend, delayed memory = 0.045, subtraction = 0.04). After adjusting for socioeconomic and vascular variables, these relationships remained robust for the highest P gingivalis IgG group (delayed verbal memory OR 3.01 (95% CI 1.06 to 8.53); subtraction OR 2.00 (95% CI 1.19 to 3.36)). In contrast, immediate verbal memory was not significantly associated with P gingivalis. Conclusion: A serological marker of periodontitis is associated with impaired delayed memory and calculation. Further exploration of relationships between oral health and cognition is warranted.

18 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JNJames M. Noble
James M. Noble
NSNikolaos Scarmeas
Nikolaos Scarmeas
RCRomanita S. Celenti
Romanita S. Celenti
MEMitchell S. V. Elkind
Mitchell S. V. Elkind
CWClinton B. Wright
Clinton B. Wright
PPPanos N. Papapanou
Panos N. Papapanou
Periodontitis and Alzheimer disease (AD) are associated with systemic inflammation. This research studied serum IgG to periodontal microbiota as possible predictors of incident AD. Using a case-cohort study design, 219 subjects (110 incident AD cases and 109 controls without incident cognitive impairment at last follow-up), matched on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP), a cohort of longitudinally followed northern Manhattan residents aged >65 years. Mean follow-up was five years (SD 2.6). In baseline sera, serum IgG levels were determined for bacteria known to be positively or negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2). In all analyses, we used antibody threshold levels shown to correlate with presence of moderate-severe periodontitis. Mean age was 72 years (SD 6.9) for controls, and 79 years (SD 4.6) for cases (p640 ng/ml, present in 10% of subjects) was associated with increased risk of AD (HR = 2.0, 95%CI: 1.1–3.8). This association was stronger after adjusting for other significant titers (HR = 3.1, 95%CI: 1.5–6.4). In this model, high anti-E. nodatum IgG (>1755 ng/ml; 19% of subjects) was associated with lower risk of AD (HR = 0.5, 95%CI: 0.2–0.9). Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.

1 January 2010 in Archives of Neurology
Verified
Journal Article
Open access
JNJames M. Noble
James M. Noble
JMJennifer J. Manly
Jennifer J. Manly
NSNicole Schupf
Nicole Schupf
MTMing Xing Tang
Ming Xing Tang
RMRichard Mayeux
Richard Mayeux
JLJosé A. Luchsinger
José A. Luchsinger
Creactive protein (CRP) is known to be elevated in those with risk factors common to stroke and dementia, including diabetes,1,2 obesity,3 and smoking,4 and is associated with adverse risk of cardiovascular disease,5 increased risk of primary stroke,6 and increased stroke severity.7 High-sensitivity CRP (hsCRP) is increasingly used in clinical practice as a marker of cardiovascular risk and to guide therapy.8 Cardiovascular disease9 and inflammation may also be important in Alzheimer disease,10 and hsCRP has been suggested to be an Alzheimer disease biomarker.11 We sought to investigate the cross-sectional association between hsCRP and impairment in specific cognitive domains among a multiethnic nondemented elderly population in northern Manhattan.

22 August 2013 in Current Neurology and Neuroscience Reports
Verified
Journal Article
Closed access
PDF file
JNJames M. Noble
James M. Noble
NSNikolaos Scarmeas
Nikolaos Scarmeas
PPPanos N. Papapanou
Panos N. Papapanou